WASHINGTON (dpa-AFX) - Zoetis Inc. (ZTS) on Wednesday announced that Health Canada has approved Lenivia for the alleviation of pain associated with osteoarthritis (OA) in dogs.
Lenivia demonstrated a strong safety profile in a nine-month field study, with dogs showing improved mobility and reduced pain after a single injection.
The company said Lenivia relieves OA pain for three months with a single injection through its novel binding to nerve growth factor (NGF), a key mediator of pain and inflammation.
Copyright(c) 2025 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2025 AFX News
